Obesity and PCOS: the Effect of Metabolic Derangements on Endometrial Receptivity at the Time of Implantation

Overview

Journal Reprod Sci

Publisher Springer

Specialty Reproductive Medicine

Date 2014 Dec 10

PMID 25488942

Citations 49

Authors

Maureen M B Schulte

Jui-he Tsai

Kelle H Moley

Affiliations

Soon will be listed here.

Abstract

Successful embryonic implantation is the result of a receptive endometrium, a functional embryo at the blastocyst stage and a synchronized dialog between maternal and embryonic tissues. Successful implantation requires the endometrium to undergo steroid-dependent change during each menstrual cycle, exhibiting a short period of embryonic receptivity known as the window of implantation. The term "endometrial receptivity" was introduced to define the state of the endometrium during the window of implantation. It refers to the ability of the endometrium to undergo changes that will allow the blastocyst to attach, penetrate, and induce localized changes in the endometrial stroma. These changes are metabolically demanding, and glucose metabolism has been proven to be important for the preparation of the endometrium for embryo implantation. Obesity and polycystic ovary syndrome (PCOS) represent 2 common metabolic disorders that are associated with subfertility. The aim of this review is to summarize the effect of obesity and PCOS on endometrial receptivity at the time of implantation. Focus will be on metabolic alterations that regulate decidualization, including glucose metabolism, hyperinsulinemia, and hyperandrogenism.

Citing Articles

Factors influencing endometrial receptivity in women with recurrent implantation failure.

Opuchlik K, Pankiewicz K, Pierzynski P, Sierdzinski J, Aleksejeva E, Salumets A BMC Womens Health. 2025; 25(1):15.

PMID: 39789542 PMC: 11715555. DOI: 10.1186/s12905-024-03531-z.

Transcriptomic alterations in the ovine caruncular endometrium due to imbalanced nutrition and FSH-induced ovarian hyperstimulation.

Bedir O, Tavares Pereira M, Rehrauer H, Grazul-Bilska A, Kowalewski M BMC Genomics. 2024; 25(1):1216.

PMID: 39695382 PMC: 11657856. DOI: 10.1186/s12864-024-10799-w.

High androgen level during controlled ovarian stimulation cycle impairs endometrial receptivity in PCOS patients.

Wei S, Zhang J, Guan H, Cai J, Jiang X, Wang H Sci Rep. 2024; 14(1):23100.

PMID: 39367050 PMC: 11452613. DOI: 10.1038/s41598-024-74295-7.

ZEB1 Promotes Epithelial-Mesenchymal Transition of Endometrial Epithelial Cells and Plays a Critical Role in Embryo Implantation in Mice.

Xu Z, Yang H, Chen H, Huang B, Yang M, Liao Z Reprod Sci. 2024; .

PMID: 39218837 DOI: 10.1007/s43032-024-01646-0.

The Impacts of Inflammatory and Autoimmune Conditions on the Endometrium and Reproductive Outcomes.

Cuadrado-Torroglosa I, Garcia-Velasco J, Alecsandru D J Clin Med. 2024; 13(13).

PMID: 38999290 PMC: 11242609. DOI: 10.3390/jcm13133724.

References

Halberg N, Wernstedt-Asterholm I, Scherer P . The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am. 2008; 37(3):753-68, x-xi. PMC: 2659415. DOI: 10.1016/j.ecl.2008.07.002. View

Frolova A, Flessner L, Chi M, Kim S, Foyouzi-Yousefi N, Moley K . Facilitative glucose transporter type 1 is differentially regulated by progesterone and estrogen in murine and human endometrial stromal cells. Endocrinology. 2008; 150(3):1512-20. PMC: 2654750. DOI: 10.1210/en.2008-1081. View

Toulis K, Goulis D, Farmakiotis D, Georgopoulos N, Katsikis I, Tarlatzis B . Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update. 2009; 15(3):297-307. DOI: 10.1093/humupd/dmp006. View

Giallauria F, Palomba S, Vigorito C, Tafuri M, Colao A, Lombardi G . Androgens in polycystic ovary syndrome: the role of exercise and diet. Semin Reprod Med. 2009; 27(4):306-15. DOI: 10.1055/s-0029-1225258. View

Kim S, Moley K . Regulation of facilitative glucose transporters and AKT/MAPK/PRKAA signaling via estradiol and progesterone in the mouse uterine epithelium. Biol Reprod. 2009; 81(1):188-98. PMC: 3093992. DOI: 10.1095/biolreprod.108.072629. View

Dessolle L, Darai E, Cornet D, Rouzier R, Coutant C, Mandelbaum J . Determinants of pregnancy rate in the donor oocyte model: a multivariate analysis of 450 frozen-thawed embryo transfers. Hum Reprod. 2009; 24(12):3082-9. DOI: 10.1093/humrep/dep303. View

Wise L, Rothman K, Mikkelsen E, Sorensen H, Riis A, Hatch E . An internet-based prospective study of body size and time-to-pregnancy. Hum Reprod. 2009; 25(1):253-64. PMC: 2794667. DOI: 10.1093/humrep/dep360. View

Aghajanova L, Velarde M, Giudice L . Altered gene expression profiling in endometrium: evidence for progesterone resistance. Semin Reprod Med. 2010; 28(1):51-8. DOI: 10.1055/s-0029-1242994. View

Bellver J, Ayllon Y, Ferrando M, Melo M, Goyri E, Pellicer A . Female obesity impairs in vitro fertilization outcome without affecting embryo quality. Fertil Steril. 2009; 93(2):447-54. DOI: 10.1016/j.fertnstert.2008.12.032. View

10.

Agarwal N, Rice S, Bolusani H, Luzio S, Dunseath G, Ludgate M . Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. J Clin Endocrinol Metab. 2009; 95(2):722-30. DOI: 10.1210/jc.2009-1985. View

11.

DeUgarte D, DeUgarte C, Sahakian V . Surrogate obesity negatively impacts pregnancy rates in third-party reproduction. Fertil Steril. 2009; 93(3):1008-10. DOI: 10.1016/j.fertnstert.2009.07.1005. View

12.

Fornes R, Ormazabal P, Rosas C, Gabler F, Vantman D, Romero C . Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia. Mol Med. 2009; 16(3-4):129-36. PMC: 2792869. DOI: 10.2119/molmed.2009.00118. View

13.

Apparao K, Lovely L, Gui Y, Lininger R, Lessey B . Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod. 2002; 66(2):297-304. DOI: 10.1095/biolreprod66.2.297. View

14.

Nestler J, Stovall D, Akhter N, Iuorno M, Jakubowicz D . Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril. 2002; 77(2):209-15. DOI: 10.1016/s0015-0282(01)02963-6. View

15.

Gregory C, Wilson E, Apparao K, Lininger R, Meyer W, Kowalik A . Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clin Endocrinol Metab. 2002; 87(6):2960-6. DOI: 10.1210/jcem.87.6.8572. View

16.

Cermik D, Selam B, Taylor H . Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003; 88(1):238-43. DOI: 10.1210/jc.2002-021072. View

17.

Bellver J, Rossal L, Bosch E, Zuniga A, Corona J, Melendez F . Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril. 2003; 79(5):1136-40. DOI: 10.1016/s0015-0282(03)00176-6. View

18.

Mozzanega B, Mioni R, Granzotto M, Chiarelli S, Xamin N, Zuliani L . Obesity reduces the expression of GLUT4 in the endometrium of normoinsulinemic women affected by the polycystic ovary syndrome. Ann N Y Acad Sci. 2005; 1034:364-74. DOI: 10.1196/annals.1335.038. View

19.

Lathi R, Hess A, Tulac S, Nayak N, Conti M, Giudice L . Dose-dependent insulin regulation of insulin-like growth factor binding protein-1 in human endometrial stromal cells is mediated by distinct signaling pathways. J Clin Endocrinol Metab. 2004; 90(3):1599-606. DOI: 10.1210/jc.2004-1676. View

20.

Kumar A, Woods K, Bartolucci A, Azziz R . Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2005; 62(6):644-9. DOI: 10.1111/j.1365-2265.2005.02256.x. View